Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nobuyuki Yamamoto

Survival Analysis for Patients With ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated With Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401

Oncologist

English

Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders With Advanced Non‐Small Cell Lung Cancer

English

Comparison of Passive Stiffness Changes in the Supraspinatus Muscle After Double-Row and Knotless Transosseous-Equivalent Rotator Cuff Repair Techniques: A Cadaveric Study

Arthroscopy - Journal of Arthroscopic and Related Surgery

English

Phase II Study of Erlotinib Plus Tivantinib (ARQ 197) in Patients With Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Just After Progression on EGFR-TKI, Gefitinib or Erlotinib

English

Re-Biopsy Status Among Non-Small Cell Lung Cancer Patients in Japan: A Retrospective Study

English

Corrigendum to “Analysis of Central Nervous System Efficacy in the J-Alex Study of Alectinib Versus Crizotinib in ALK-positive Non-Small-Cell Lung Cancer” [Lung Cancer 121 (July) (2018) Pages 37–40]

English

A Randomized, Double-Blind, Phase II Study of Ramucirumab Plus Docetaxel vs Placebo Plus Docetaxel in Japanese Patients With Stage IV Non-Small Cell Lung Cancer After Disease Progression on Platinum-Based Therapy

English

Osimertinib With Ramucirumab in EGFR Mutated, T790m-Positive Patients Who Had Progressed EGFR-TKIs: Phase Ib Study

English

Detection of AXL Expression in Circulating Tumor Cells of Lung Cancer Patients Using an Automated Microcavity Array System

English

Furosemide Versus Mannitol in Japanese Patients With Thoracic Malignancy Who Received Cisplatin-Based Chemotherapy Using Short Hydration: Study Protocol for a Randomised Controlled Trial

BMJ Open

Medicine

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nobuyuki Yamamoto

Survival Analysis for Patients With ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated With Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401

Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders With Advanced Non‐Small Cell Lung Cancer

Comparison of Passive Stiffness Changes in the Supraspinatus Muscle After Double-Row and Knotless Transosseous-Equivalent Rotator Cuff Repair Techniques: A Cadaveric Study

Phase II Study of Erlotinib Plus Tivantinib (ARQ 197) in Patients With Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Just After Progression on EGFR-TKI, Gefitinib or Erlotinib

Re-Biopsy Status Among Non-Small Cell Lung Cancer Patients in Japan: A Retrospective Study

Corrigendum to “Analysis of Central Nervous System Efficacy in the J-Alex Study of Alectinib Versus Crizotinib in ALK-positive Non-Small-Cell Lung Cancer” [Lung Cancer 121 (July) (2018) Pages 37–40]

A Randomized, Double-Blind, Phase II Study of Ramucirumab Plus Docetaxel vs Placebo Plus Docetaxel in Japanese Patients With Stage IV Non-Small Cell Lung Cancer After Disease Progression on Platinum-Based Therapy

Osimertinib With Ramucirumab in EGFR Mutated, T790m-Positive Patients Who Had Progressed EGFR-TKIs: Phase Ib Study

Detection of AXL Expression in Circulating Tumor Cells of Lung Cancer Patients Using an Automated Microcavity Array System

Furosemide Versus Mannitol in Japanese Patients With Thoracic Malignancy Who Received Cisplatin-Based Chemotherapy Using Short Hydration: Study Protocol for a Randomised Controlled Trial